Milna neuraxpharm 50mg Milnacipran

Milna neuraxpharm is a pharmaceutical product containing Milnacipran, primarily used for the treatment of major depressive episodes. The brand 'neuraxpharm' is a leader in Central Nervous System (CNS) treatments across Europe.

Originally founded in Germany, neuraxpharm has expanded significantly through mergers and acquisitions, most notably the 2016 merger with Medichem to form the Neuraxpharm Group. The company maintains significant manufacturing and research facilities in Germany and Spain, supplying numerous European markets. Today, the brand is owned by the global investment firm Permira, which focuses on long-term growth in the healthcare and technology sectors.